PURPLE BIOTECH LTD's ticker is PPBT and the CUSIP is 74638P109. A total of 18 filers reported holding PURPLE BIOTECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -33.3% | 7,773 | -15.1% | 0.00% | – |
| Q2 2023 | $12 | -64.7% | 9,158 | -53.5% | 0.00% | – |
| Q1 2023 | $34 | -99.7% | 19,703 | +232.9% | 0.00% | – |
| Q3 2022 | $12,000 | +140.0% | 5,918 | +138.7% | 0.00% | – |
| Q2 2022 | $5,000 | -78.3% | 2,479 | -56.8% | 0.00% | – |
| Q1 2021 | $23,000 | – | 5,735 | +3397.0% | 0.00% | – |
| Q4 2020 | $0 | – | 164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 346,197 | $1,319,000 | 0.01% |
| Virtu Financial LLC | 22,988 | $88,000 | 0.01% |
| WASHINGTON TRUST BANK | 16,454 | $63,000 | 0.01% |
| TRUE Private Wealth Advisors | 6,700 | $25,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,800 | $110,000 | 0.00% |
| Your Advocates Ltd., LLP | 400 | $2,000 | 0.00% |
| Renaissance Technologies | 128,900 | $491,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| North Star Investment Management Corp. | 300 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 26,167 | $100,000 | 0.00% |